Elsie Cheang
Lawyers
Filters
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
Personalis $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Revolution Medicines $750 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Alkami Technology $281.25 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Alkami Technology $155.9 million secondary offering
The shares are listed on the Nasdaq Global Select Market
MKS Instruments $1.4 billion convertible notes offering
The 1.25% convertible notes are due 2030
Sunrun $475 million convertible notes offering and capped call transactions
The convertible notes are due 2030
Tenaya Therapeutics $50 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Atara Biotherapeutics $100 million at-the-market offering
The stock is listed on Nasdaq
AVITA Medical at-the-market offering
The stock is listed on the Nasdaq Global Market